Research is underway to develop alternative treatments for corneal endothelial diseases, which are less dependent on the availability of allogeneic tissues – regenerative medicine and cell-based ...

Background/aims To study human corneal endothelial cells (HCECs) cultured in vitro with human serum (HS) supplemented media (HS-SM) compared with HCEC cultured in fetal bovine serum (FBS) supplemented ...

Vyznova a human corneal endothelial cell therapy. It is formulated as solution for intracameral route of administration. Vyznova is indicated for the treatment of bullous keratopathy of the cornea. AE ...

Monocytes are circulating leukocytes of innate immunity derived from the bone marrow that interact with endothelial cells under physiological or pathophysiological conditions to orchestrate ...

Cell therapy company Aurion Biotech is moving forward with plans to IPO despite a pending lawsuit from one of its existing ...

Besides endothelial cell death, phenotypic conversion and acquisition of myofibroblast-like characteristics may also contribute to the development of cardiac fibrosis, the structural correlate of ...

FECD affects the corneal endothelial cells, which form a layer responsible ... how this mechanism plays out throughout human development to better understand when may be the most effective time ...

SING IMT improved distance and near vision in AMD patients, with minimal impact on corneal endothelial cell density and manageable safety outcomes. At 6 months post-surgery, 97.1% of patients achieved ...

Request permissions for this article.